|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 321.70 CHF | -0.34% |
|
+2.38% | -1.98% |
| May. 18 | MPP and Roche sign voluntary licence agreement for baloxavir marboxil | RE |
| May. 18 | Roche, Medicines Patent Pool sign deal to expand access to influenza drug | RE |
Turnover - Evolution of Analysts' Estimates
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
EBIT - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Cash or Net Debt - Evolution of Analysts' Estimates
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
Turnover
Earnings Per Share (EPS)
EBIT
Dividend / Share (DPS)
Cash or Net Debt
- Stock Market
- Equities
- ROP Stock
- ROG Stock
- Consensus Roche Holding AG
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
